H U Group HoldingsTSE:4544 +1.44%68 Net Margin % is 2.01% as of Mar. 2026, which is 3% above its 10-year median of 1.95. GuruFocus rates TSE:4544 with a GF Score™ of 68/100 and a GF Value™ of 円2,771.74 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 204 Medical Diagnostics & Research companies, H U Group Holdings ranks better than 59.31% on this metric.
The historical rank and industry rank for H U Group Holdings's Net Margin % or its related term are showing as below:
TSE:4544'
s Net Margin % Range Over the Past 10 Years
Min: -3.19 Med: 1.95 Max: 10.84
Current: 2.76
TSE:4544's Net Margin % is ranked better than 59.31% of 204
companies
in the Medical Diagnostics & Research industry
Industry Median: -2.405
vs TSE:4544: 2.76
H U Group Holdings (TSE:4544) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
H U Group Holdings Net Margin % Related Terms
H U Group Holdings Net Margin % Historical Data
* Premium members only.
The historical data trend for H U Group Holdings's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:4544 vs TMO, DHR, IDXX: Net Margin % Comparison
For the Diagnostics & Research subindustry, H U Group Holdings's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
H U Group Holdings Net Margin % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, H U Group Holdings's Net Margin % distribution charts can be found below:
* The bar in red indicates where H U Group Holdings's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
H U Group Holdings (TSE:4544) has a Net Margin % of 2.01% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on H U Group Holdings and its competitors. This is near median its historical median of 1.95. According to the industry distribution chart, H U Group Holdings ranks #83 out of 204 companies in the Medical Diagnostics & Research industry, placing it in the top 40.7%.
Is H U Group Holdings' Net Margin % too high?
H U Group Holdings' current Net Margin % of 2.01% is near median its 10-year median of 1.95. Based on the distribution chart, H U Group Holdings ranks #83 out of 204 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, H U Group Holdings has a GF Score™ of 68/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does H U Group Holdings' Net Margin % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, H U Group Holdings ranks #83 out of 204 companies for Net Margin %. This puts H U Group Holdings in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Diagnostics & Research company?
A good Net Margin % depends on the Medical Diagnostics & Research industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on H U Group Holdings and its competitors. H U Group Holdings's current Net Margin % is 2.01%, which is near median its own 10-year median of 1.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is H U Group Holdings stock overvalued right now?
Based on GuruFocus' analysis, H U Group Holdings (TSE:4544) is currently considered Modestly Overvalued. The stock's GF Value™ is 円2,771.74, compared to a current price of 円3,244.00 — trading 17% above its estimated fair value. The current Net Margin % is 2.01%, which is near median its 10-year median of 1.95. H U Group Holdings' overall GF Score™ is 68/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For H U Group Holdings (TSE:4544), the current Net Margin % is 2.01% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is H U Group Holdings (TSE:4544) Overvalued in 2026?
Based on GuruFocus' analysis, H U Group Holdings stock appears to be overvalued.
The current stock price of 円3,244.00 is trading 17% above its estimated GF Value™ of 円2,771.74.
GuruFocus considers H U Group Holdings to be Modestly Overvalued.
Key valuation signals for TSE:4544:
Net Margin %: 2.01% (near median its 10-year median of 1.95)
GF Value™: 円2,771.74 vs. price of 円3,244.00 (17% above fair value)
No single metric tells the full story. See the TSE:4544 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
H U Group Holdings Inc operates in the healthcare field, focusing on clinical laboratory testing and reagents. The company is engaged in four main businesses. The Clinical Laboratory Testing Business receives samples taken from patients at medical institutions to test for the disease and confirm the condition of the patient's health; In Vitro Diagnostics develops, manufactures, and sells testing reagents and equipment inside and outside Japan; Sterilization & Related Services Business provides a range of medical-related services including sterilization; and Emerging New Business & Others is a new business for future growth.
68GF Score
Get the complete analysis for TSE:4544
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4544 has been successfully added to your 
